COVID-19 Infection and Haematological Involvement : a Review of Epidemiology, Pathophysiology and Prognosis of Full Blood Count Findings
© Springer Nature Switzerland AG 2020..
The unfolding COVID-19 pandemic began in December 2019 in Wuhan, Hubei Province. COVID-19 is a systemic infection affecting several systems including the haematopoietic system. Surveys illustrating the laboratory findings of these patients conclude that lymphocytopenia, neutrophilia and thrombocytopenia are prominent amongst them. Moreover, it has been reported a significant decrease in T lymphocyte subsets and an increase of inflammatory cytokines of hospitalized patients with COVID-19. Generally, thrombocytopenia is commonplace in critically ill patients and usually suggests serious organ malfunction. In view of this, this review investigates the correlation between these abnormalities and the prognosis and disease course. Full blood count is an easy, economic and widely available tool which may help to discriminate between patients with or without severe disease. Last but not least, this review examines potential pathophysiological mechanisms by the novel coronavirus which contribute to these haematological alterations aiding the clinicians to better understand this disease and provide more clinical treatment options.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:2 |
---|---|
Enthalten in: |
SN comprehensive clinical medicine - 2(2020), 8 vom: 10., Seite 1089-1093 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Violetis, Odyssefs A [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Date Revised 07.07.2022 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1007/s42399-020-00380-3 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM314115943 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM314115943 | ||
003 | DE-627 | ||
005 | 20231225152037.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s42399-020-00380-3 |2 doi | |
028 | 5 | 2 | |a pubmed24n1047.xml |
035 | |a (DE-627)NLM314115943 | ||
035 | |a (NLM)32838152 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Violetis, Odyssefs A |e verfasserin |4 aut | |
245 | 1 | 0 | |a COVID-19 Infection and Haematological Involvement |b a Review of Epidemiology, Pathophysiology and Prognosis of Full Blood Count Findings |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 07.07.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a © Springer Nature Switzerland AG 2020. | ||
520 | |a The unfolding COVID-19 pandemic began in December 2019 in Wuhan, Hubei Province. COVID-19 is a systemic infection affecting several systems including the haematopoietic system. Surveys illustrating the laboratory findings of these patients conclude that lymphocytopenia, neutrophilia and thrombocytopenia are prominent amongst them. Moreover, it has been reported a significant decrease in T lymphocyte subsets and an increase of inflammatory cytokines of hospitalized patients with COVID-19. Generally, thrombocytopenia is commonplace in critically ill patients and usually suggests serious organ malfunction. In view of this, this review investigates the correlation between these abnormalities and the prognosis and disease course. Full blood count is an easy, economic and widely available tool which may help to discriminate between patients with or without severe disease. Last but not least, this review examines potential pathophysiological mechanisms by the novel coronavirus which contribute to these haematological alterations aiding the clinicians to better understand this disease and provide more clinical treatment options | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Cytokine release syndrome | |
650 | 4 | |a Lymphocytopenia | |
650 | 4 | |a Neutrophilia | |
650 | 4 | |a SARS-CoV-2 | |
650 | 4 | |a Thrombocytopenia | |
650 | 4 | |a White blood cells | |
700 | 1 | |a Chasouraki, Angeliki M |e verfasserin |4 aut | |
700 | 1 | |a Giannou, Alexandra M |e verfasserin |4 aut | |
700 | 1 | |a Baraboutis, Ioannis G |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t SN comprehensive clinical medicine |d 2019 |g 2(2020), 8 vom: 10., Seite 1089-1093 |w (DE-627)NLM300071965 |x 2523-8973 |7 nnns |
773 | 1 | 8 | |g volume:2 |g year:2020 |g number:8 |g day:10 |g pages:1089-1093 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s42399-020-00380-3 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 2 |j 2020 |e 8 |b 10 |h 1089-1093 |